{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:16:25Z","timestamp":1770513385318,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12933-016-0331-7","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T17:45:51Z","timestamp":1452966351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression"],"prefix":"10.1186","volume":"15","author":[{"given":"Laura","family":"Gonzalez-Calero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Martin-Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"de la Cuesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aroa S.","family":"Maroto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Baldan-Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Ruiz-Hurtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Pulido-Olmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Segura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria G.","family":"Barderas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis M.","family":"Ruilope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Vivanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Alvarez-Llamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,16]]},"reference":[{"key":"331_CR1","first-page":"375","volume":"20","author":"PE Jong De","year":"2007","unstructured":"De Jong PE, Gansevoort RT, Bakker SJ. Macroalbuminuria and microalbuminuria do both predict renal and cardiovascular events with similar strength? J Nephrol. 2007;20:375\u201380.","journal-title":"J Nephrol"},{"key":"331_CR2","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073\u201381.","journal-title":"Lancet"},{"key":"331_CR3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/HJH.0b013e32834d9e0f","volume":"30","author":"C Cerezo","year":"2012","unstructured":"Cerezo C, Ruilope LM, Segura J, Garcia-Donaire JA, de la Cruz JJ, Banegas JR, et al. Microalbuminuria breakthrough under chronic renin-angiotensin-aldosterone system suppression. J Hypertens. 2012;30:204\u20139.","journal-title":"J Hypertens"},{"key":"331_CR4","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/dc13-1870","volume":"37","author":"GL Bakris","year":"2014","unstructured":"Bakris GL, Molitch M. Microalbuminuria as a risk predictor in diabetes: the continuing saga. Diabetes Care. 2014;37:867\u201375.","journal-title":"Diabetes Care"},{"key":"331_CR5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.2010.39","volume":"303","author":"BR Hemmelgarn","year":"2010","unstructured":"Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010;303:423\u20139.","journal-title":"JAMA"},{"issue":"25","key":"331_CR6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","volume":"2007","author":"G Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Management of Arterial Hypertension of the European Society of Hypertension, European Society of Cardiology, et al. Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;2007(25):1105\u201387.","journal-title":"J Hypertens"},{"key":"331_CR7","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1053\/ajkd.2002.30944","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease. Part 5. Evaluation of laboratory measurements for clinical assessment of kidney disease. Am J Kidney Dis. 2002;39:S76\u2013110.","journal-title":"Am J Kidney Dis"},{"key":"331_CR8","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/HYPERTENSIONAHA.114.04273","volume":"64","author":"JM Pascual","year":"2014","unstructured":"Pascual JM, Rodilla E, Costa JA, Garcia-Escrich M, Gonzalez C, Redon J. Prognostic value of micoralbuminuria during antihypertensive treatment in essential hypertension. Hypertension. 2014;64:1228\u201334.","journal-title":"Hypertension"},{"key":"331_CR9","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1097\/HJH.0000000000000292","volume":"32","author":"G Ruiz-Hurtado","year":"2014","unstructured":"Ruiz-Hurtado G, Condezo-Hoyos L, Pulido-Olmo H, Aranguez I, Del Carmen G\u00f3nzalez M, Arribas S, et al. Development of albuminuria and enhancement of oxidative stress during chronic renin-angiotensin system suppression. J Hypertens. 2014;32:2082\u201391.","journal-title":"J Hypertens"},{"key":"331_CR10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/dme.12447","volume":"31","author":"MJ Pena","year":"2014","unstructured":"Pena MJ, Lambers Heerspink HJ, Hellemons ME, Friedrich T, Dallmann G, Lajer M, et al. Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus. Diabet Med. 2014;31:1138\u201347.","journal-title":"Diabet Med"},{"key":"331_CR11","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2337\/dc12-0180","volume":"35","author":"ME Hellemons","year":"2012","unstructured":"Hellemons ME, Mazagova M, Gansevoort RT, Henning RH, de Zeeuw D, Bakker SJ, et al. Growth-differentiation factor 15 predicts worsening of albuminuria in patients with type 2 diabetes. Diabetes Care. 2012;35:2340\u20136.","journal-title":"Diabetes Care"},{"key":"331_CR12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrneph.2009.183","volume":"5","author":"MP Smith","year":"2009","unstructured":"Smith MP, Banks RE, Wood SL, Lewington AJ, Selby PJ. Application of proteomic analysis to the study of renal diseases. Nat Rev Nephrol. 2009;5:701\u201312.","journal-title":"Nat Rev Nephrol"},{"key":"331_CR13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1373\/clinchem.2011.165969","volume":"58","author":"A Konvalinka","year":"2012","unstructured":"Konvalinka A, Scholey JW, Diamandis EP. Searching for new biomarkers of renal diseases through proteomics. Clin Chem. 2012;58:353\u201365.","journal-title":"Clin Chem"},{"key":"331_CR14","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1093\/ndt\/gfu234","volume":"29","author":"YM Gu","year":"2014","unstructured":"Gu YM, Thijs L, Liu YP, Zhang Z, Jacobs L, Koeck T, et al. The urinary proteome as correlate and predictor of renal function in a population study. Nephrol Dial Transplant. 2014;29:2260\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"331_CR15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00592-012-0407-0","volume":"49","author":"A Soggiu","year":"2012","unstructured":"Soggiu A, Piras C, Bonizzi L, Hussein HA, Pisanu S, Roncada P. A discovery-phase urine proteomics investigation in type 1 diabetes. Acta Diabetol. 2012;49:453\u201364.","journal-title":"Acta Diabetol"},{"key":"331_CR16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/14789450.2.3.349","volume":"2","author":"V Thongboonkerd","year":"2005","unstructured":"Thongboonkerd V. Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery. Expert Rev Proteomics. 2005;2:349\u201366.","journal-title":"Expert Rev Proteomics"},{"key":"331_CR17","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s11306-014-0761-8","volume":"11","author":"Marta Martin-Lorenzo","year":"2015","unstructured":"Martin-Lorenzo Marta, Zubiri Irene, Maroto Aroa S, Gonzalez-Calero L, Posada-Ayala M, de la Cuesta F, et al. KLK1 and ZG16B proteins and arginine\u2013proline metabolism identified as novel targets to monitor atherosclerosis, acute coronary syndrome and recovery. Metabolomics. 2015;11:1056\u201367.","journal-title":"Metabolomics"},{"key":"331_CR18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jprot.2013.10.037","volume":"96","author":"I Zubiri","year":"2014","unstructured":"Zubiri I, Posada-Ayala M, Sanz-Maroto A, Calvo E, Martin-Lorenzo M, Gonzalez-Calero L, et al. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis. J Proteomics. 2014;96:92\u2013102.","journal-title":"J Proteomics"},{"key":"331_CR19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5414\/CNP68269","volume":"68","author":"P Dennen","year":"2007","unstructured":"Dennen P, Parikh CR. Biomarkers of acute kidney injury: can we replace serum creatinine? Clin Nephrol. 2007;68:269\u201378.","journal-title":"Clin Nephrol"},{"key":"331_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ki.2013.328","volume":"85","author":"M Posada-Ayala","year":"2014","unstructured":"Posada-Ayala M, Zubiri I, Martin-Lorenzo M, Sanz-Maroto A, Molero D, Gonzalez-Calero L, et al. Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease. Kidney Int. 2014;85:103\u201311.","journal-title":"Kidney Int"},{"key":"331_CR21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1681\/ASN.2006070767","volume":"18","author":"SA Varghese","year":"2007","unstructured":"Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, et al. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol. 2007;18:913\u201322.","journal-title":"J Am Soc Nephrol"},{"key":"331_CR22","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1002\/elps.201300601","volume":"35","author":"M Martin-Lorenzo","year":"2014","unstructured":"Martin-Lorenzo M, Gonzalez-Calero L, Zubiri I, Diaz-Payno PJ, Sanz-Maroto A, Posada-Ayala M, et al. Urine 2DE proteome analysis in healthy condition and kidney disease. Electrophoresis. 2014;35:2634\u201341.","journal-title":"Electrophoresis"},{"issue":"M110","key":"331_CR23","first-page":"003517","volume":"10","author":"F Cuesta de la","year":"2011","unstructured":"de la Cuesta F, Alvarez-Llamas G, Maroto AS, Donado A, Zubiri I, Posada M, et al. A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima. Mol Cell Proteomics. 2011;10(M110):003517.","journal-title":"Mol Cell Proteomics"},{"key":"331_CR24","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1021\/pr1002017","volume":"9","author":"VM Dard\u00e9","year":"2010","unstructured":"Dard\u00e9 VM, de la Cuesta F, Dones FG, Alvarez-Llamas G, Barderas MG, Vivanco F. Analysis of the plasma proteome associated with acute coronary syndrome: does a permanent protein signature exist in the plasma of ACS patients? J Proteome Res. 2010;9:4420\u201332.","journal-title":"J Proteome Res"},{"key":"331_CR25","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1021\/ac9806005","volume":"70","author":"S Sechi","year":"1998","unstructured":"Sechi S, Chait BT. Modification of cysteine residues by alkylation. A tool in peptide mapping and protein identification. Anal Chem. 1998;70:5150\u20138.","journal-title":"Anal Chem"},{"key":"331_CR26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nmeth.2015","volume":"9","author":"P Picotti","year":"2012","unstructured":"Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods. 2012;9:555\u201366.","journal-title":"Nat Methods"},{"key":"331_CR27","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.105.538132","volume":"112","author":"J Arnl\u00f6v","year":"2005","unstructured":"Arnl\u00f6v J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112:969\u201375.","journal-title":"Circulation"},{"key":"331_CR28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/ndt\/gfp691","volume":"25","author":"PE Jong De","year":"2010","unstructured":"De Jong PE, Gansevoort RT. Albuminuria in non-primary renal disease: risk marker rather than risk factor. Nephrol Dial Transplant. 2010;25:656\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"331_CR29","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/jch.12185","volume":"15","author":"G Shlomai","year":"2013","unstructured":"Shlomai G, Grassi G, Grossman E, Mancia G. Assessment of target organ damage in the evaluation and follow-up of hypertensive patients: where do we stand? J Clin Hypertens (Greenwich). 2013;15:742\u20137.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"331_CR30","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","volume":"367","author":"HH Parving","year":"2012","unstructured":"Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. 2012;367:2204\u201313.","journal-title":"N Engl J Med"},{"key":"331_CR31","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"K Jamerson","year":"2008","unstructured":"Jamerson K, Weber MA, Bakris GL, Dahl\u00f6f B, Pitt B, Shi V, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417\u201328.","journal-title":"N Engl J Med"},{"key":"331_CR32","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1681\/ASN.2010091001","volume":"22","author":"RE Schmieder","year":"2011","unstructured":"Schmieder RE, Mann JF, Schumacher H, Gao P, Mancia G, Weber MA, et al. Changes in albuminuria predict mortality and morbidity in patients with vascular disease. J Am Soc Nephrol. 2011;22:1353\u201364.","journal-title":"J Am Soc Nephrol"},{"key":"331_CR33","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/eurheartj\/ehp546","volume":"31","author":"T Sehestedt","year":"2010","unstructured":"Sehestedt T, Jeppesen J, Hansen TW, Wachtell K, Ibsen H, Torp-Pedersen C, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2010;31:883\u201391.","journal-title":"Eur Heart J"},{"key":"331_CR34","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1038\/srep03884","volume":"4","author":"S Murai","year":"2014","unstructured":"Murai S, Tanaka S, Dohi Y, Kimura G, Ohte N. The prevalence, characteristics, and clinical significance of abnormal albuminuria in patients with hypertension. Sci Rep. 2014;4:3884.","journal-title":"Sci Rep"},{"key":"331_CR35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbacli.2014.10.001","volume":"2","author":"V Matafora","year":"2014","unstructured":"Matafora V, Zagato L, Ferrandi M, Molinari I, Zerbini G, Casamassima N, et al. Quantitative proteomics reveals novel therapeutic and diagnostic markers in hypertension. BBA Clin. 2014;2:79\u201387.","journal-title":"BBA Clin"},{"key":"331_CR36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02479938","volume":"2","author":"M Tamano","year":"1998","unstructured":"Tamano M, Ohi H. Evaluation of urinary decay accelerating factor and CD59 in renal damage. Clin Exper Nephrol. 1998;2:155\u201361.","journal-title":"Clin Exper Nephrol"},{"key":"331_CR37","doi-asserted-by":"crossref","first-page":"574261","DOI":"10.1155\/2014\/574261","volume":"2014","author":"M Nafar","year":"2014","unstructured":"Nafar M, Kalantari S, Samavat S, Rezaei-Tavirani M, Rutishuser D, Zubarev RA. The novel diagnostic biomarkers for focal segmental glomerulosclerosis. Int J Nephrol. 2014;2014:574261.","journal-title":"Int J Nephrol"},{"key":"331_CR38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2567.2007.02598.x","volume":"121","author":"B Coles","year":"2007","unstructured":"Coles B, Lewis R, Anning PB, Morton J, Baalasubramanian S, Morgan BP, et al. CD59 or C3 are not requred for angiotensin II-dependent hypertension or hypertrophy in mice. Immunology. 2007;121:518\u201325.","journal-title":"Immunology"},{"key":"331_CR39","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1097\/01.hjh.0000467672.93812.38","volume":"33","author":"F Castagna","year":"2015","unstructured":"Castagna F, Wang J, Emit M, Wang G, Jelic S, Parati G. Protection against complement activity is reduced in arterial hypertension. J Hypertens. 2015;33:e119.","journal-title":"J Hypertens"},{"key":"331_CR40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCRESAHA.108.191361","volume":"104","author":"G Wu","year":"2009","unstructured":"Wu G, Hu W, Shahsafaei A, Song W, Dobarro M, Sukhova GK, et al. Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex. Circ Res. 2009;104:550\u20138.","journal-title":"Circ Res"},{"key":"331_CR41","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.molimm.2009.10.035","volume":"47","author":"RD Lewis","year":"2010","unstructured":"Lewis RD, Jackson CL, Morgan BP, Hughes TR. The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice. Mol Immunol. 2010;47:1098\u2013105.","journal-title":"Mol Immunol"},{"key":"331_CR42","doi-asserted-by":"crossref","first-page":"e13421","DOI":"10.1371\/journal.pone.0013421","volume":"5","author":"A Alkhalaf","year":"2010","unstructured":"Alkhalaf A, Z\u00fcrbig P, Bakker SJ, Bilo HJ, Cerna M, Fischer C, et al. Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy. PLoS One. 2010;5:e13421.","journal-title":"PLoS One"},{"key":"331_CR43","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2337\/dc06-2056","volume":"30","author":"PV Rao","year":"2007","unstructured":"Rao PV, Lu X, Standley M, Pattee P, Neelima G, Girisesh G, et al. Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care. 2007;30:629\u201337.","journal-title":"Diabetes Care"},{"key":"331_CR44","first-page":"168602","volume":"2012","author":"J Jin","year":"2012","unstructured":"Jin J, Ku YH, Kim Y, Kim Y, Kim K, Lee JY, et al. Differential proteome profiling using iTRAQ in microalbuminuric and normoalbuminuric type2 diabetic patients. Exp Diabetes Res. 2012;2012:168602.","journal-title":"Exp Diabetes Res"},{"key":"331_CR45","first-page":"83","volume":"51","author":"B Lisowska-Myjak","year":"2010","unstructured":"Lisowska-Myjak B, Zboinska A, Muszynski J, Pachecka J. Comparison of urinary albumin and alpha-1-antitrypsin (AAT) excretion in consecutive stages of proteinuria in patients with diabetes mellitus. Clin Exp Med Lett. 2010;51:83\u20137.","journal-title":"Clin Exp Med Lett"},{"key":"331_CR46","doi-asserted-by":"crossref","first-page":"713","DOI":"10.20452\/pamw.536","volume":"118","author":"R Swiatkowska-Stodulska","year":"2008","unstructured":"Swiatkowska-Stodulska R, Babi\u0144ska A, Skibowska-Bieli\u0144ska A, Sworczak K. Assessment of alpha1-antitrypsin and alpha2-macroglobulin levels in obese patients. Pol Arch Med Wewn. 2008;118:713\u20138.","journal-title":"Pol Arch Med Wewn"},{"key":"331_CR47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/00365519950185814","volume":"59","author":"B Lisowska-Myjak","year":"1999","unstructured":"Lisowska-Myjak B, Pachecka J, Witak P, Radowicki S. Comparison of urinary excretion of albumin and alpha-1-antitrypsin in patients with arterial hypertension. Scand J Clin Lab Invest. 1999;59:93\u20137.","journal-title":"Scand J Clin Lab Invest"},{"key":"331_CR48","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ajh\/hpu142","volume":"27","author":"B Rodriguez-Iturbe","year":"2014","unstructured":"Rodriguez-Iturbe B, Pons H, Quiroz Y, Johnson RJ. The immunological basis of hypertension. Am J Hypertens. 2014;27:1327\u201337.","journal-title":"Am J Hypertens"},{"issue":"7","key":"331_CR49","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0002-9343(00)00567-2","volume":"109","author":"C Catena","year":"2000","unstructured":"Catena C, Zingaro L, Casaccio D, Sechi LA. Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance. Am J Med. 2000;109(7):556\u201361.","journal-title":"Am J Med"},{"key":"331_CR50","first-page":"368","volume":"27","author":"U Derhaschnig","year":"2013","unstructured":"Derhaschnig U, Testori C, Riedmueller E, Aschauer S, Wolzt M, Jilma B. Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis. Hypertension. 2013;27:368\u201373.","journal-title":"Hypertension"},{"key":"331_CR51","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","volume":"109","author":"M Levi","year":"2004","unstructured":"Levi M, van der Poll T, B\u00fcller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004;109:2698\u2013704.","journal-title":"Circulation"},{"key":"331_CR52","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/ATVBAHA.113.302918","volume":"34","author":"X Yin","year":"2014","unstructured":"Yin X, Subramanian S, Hwang SJ, O\u2019Donnell CJ, Fox CS, Courchesne P, et al. Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative. Arterioscler Thromb Vasc Biol. 2014;34:939\u201345.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"331_CR53","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1161\/CIRCULATIONAHA.113.006321","volume":"128","author":"DI Simon","year":"2013","unstructured":"Simon DI, Simon NM. Plasminogen activator inhibitor-1: a novel therapeutic target for hypertension? Circulation. 2013;128:2286\u20138.","journal-title":"Circulation"},{"key":"331_CR54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","volume":"116","author":"EL Schiffrin","year":"2007","unstructured":"Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116:85\u201397.","journal-title":"Circulation"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-016-0331-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T04:34:32Z","timestamp":1748752472000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cardiab.com\/content\/15\/1\/8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,16]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["331"],"URL":"https:\/\/doi.org\/10.1186\/s12933-016-0331-7","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,16]]},"article-number":"8"}}